Changes to pediatric brain tumors in 2021 World Health Organization classification of tumors of the central nervous system

被引:0
作者
Murat Alp Oztek
Sakura M. Noda
Erin K. Romberg
Bonnie L. Cole
Jason N. Wright
Gisele E. Ishak
Francisco A. Perez
机构
[1] University of Washington Medical Center,Department of Radiology
[2] Seattle Children’s Hospital,Department of Radiology
[3] Seattle Children’s Hospital,Department of Laboratories
[4] University of Washington School of Medicine,Department of Laboratory Medicine and Pathology
来源
Pediatric Radiology | 2023年 / 53卷
关键词
Brain; Central nervous system; Children; Classification; Magnetic resonance imaging; Neuro-oncology; Pathology; Tumor; World Health Organization;
D O I
暂无
中图分类号
学科分类号
摘要
New tumor types are continuously being described with advances in molecular testing and genomic analysis resulting in better prognostics, new targeted therapy options and improved patient outcomes. As a result of these advances, pathological classification of tumors is periodically updated with new editions of the World Health Organization (WHO) Classification of Tumors books. In 2021, WHO Classification of Tumors of the Central Nervous System, 5th edition (CNS5), was published with major changes in pediatric brain tumors officially recognized including pediatric gliomas being separated from adult gliomas, ependymomas being categorized based on anatomical compartment and many new tumor types, most of them seen in children. Additional general changes, such as tumor grading now being done within tumor types rather than across entities and changes in definition of glioblastoma, are also relevant to pediatric neuro-oncology practice. The purpose of this manuscript is to highlight the major changes in pediatric brain tumors in CNS5 most relevant to radiologists. Additionally, brief descriptions of newly recognized entities will be presented with a focus on imaging findings.
引用
收藏
页码:523 / 543
页数:20
相关论文
共 256 条
[51]  
Aldape K(2019)Aggressive supratentorial ependymoma, RELA fusion-positive with extracranial metastasis: a case report Clin Neuroradiol 29 143-259
[52]  
Andreiuolo F(2018)Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling Brain Tumor Pathol 35 211-797
[53]  
Lisner T(2011)Preoperative and intraoperative perfusion magnetic resonance imaging in a RELA fusion-positive anaplastic ependymoma: A case report Cancer Cell 20 2468-1089
[54]  
Zlocha J(2018)MRI phenotype of RELA-fused pediatric supratentorial ependymoma Acta Neuropathol 136 1451-430
[55]  
Vettermann FJ(2016)RELA fusion-positive anaplastic ependymoma: molecular characterization and advanced MR imaging J Clin Oncol 34 227-467
[56]  
Felsberg J(2016)Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma Neuro Oncol 18 986-343
[57]  
Reifenberger G(2018)Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas Acta Neuropathol 136 2017-494
[58]  
Kurokawa R(2021)Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis Neuro Oncol 24 v1-524
[59]  
Baba A(2012)Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma Childs Nerv Syst 28 377-171
[60]  
Kurokawa M(2019)Heterogeneity within the PF-EPN-B ependymoma subgroup Neuro Oncol 21 254-488